Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics: Eric Santa, Jeff Borcherding

Myriad Genetics has hired Eric Santa, previously chief revenue officer at UnitedHealth Group's Rally Health, as its new chief growth officer. Santa will report to Myriad CEO Paul Diaz and lead marketing, digital, branding, and communications initiatives that grow the company's presence and reach. He will also spearhead efforts to glean new genetic insights using Myriad's patient database and identify expansion opportunties. 

Additionally, Jeff Borcherding, previously a general manager leading sales and marketing efforts for the GeneSight pharmacogenetic test, has been promoted to senior VP and chief marketing officer within Santa's team. Borcherding will now focus on increasing test volumes and revenues within Myriad's integrated product marketing initiatives.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.